Fosaprepitant Intravenous and Insulin lispro Subcutaneous
Determining the interaction of Fosaprepitant Intravenous and Insulin lispro Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fosaprepitant Intravenous-Insulin NPH
- Fosaprepitant Intravenous-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Fosaprepitant Intravenous-Insulin NPH (Vials)
- Fosaprepitant Intravenous-Insulin NPH and Insulin Regular
- Fosaprepitant Intravenous-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Fosaprepitant Intravenous-Insulin NPH and Insulin Regular (Vials)
- Insulin lispro Subcutaneous-Foscarnet
- Insulin lispro Subcutaneous-Foscarnet Intravenous
- Insulin lispro Subcutaneous-Foscarnet Sodium
- Insulin lispro Subcutaneous-Foscavir
- Insulin lispro Subcutaneous-Fosfomycin
- Insulin lispro Subcutaneous-Fosfomycin Tromethamine